These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3730748)

  • 1. Use of Haleraid in rheumatoid arthritis with obstructive lung disease.
    Wolstenholme RJ; Shettar SP; Taher F; Hatton B
    Br J Rheumatol; 1986 Aug; 25(3):318. PubMed ID: 3730748
    [No Abstract]   [Full Text] [Related]  

  • 2. The place for albuterol aerosol in chronic obstructive airway disease: maximizing its use.
    Middleton E
    Ann Allergy; 1981 Nov; 47(5 Pt 2):427-8. PubMed ID: 6795977
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow up of small airways obstruction in patients with rheumatoid arthritis.
    Wright GD; Roberts SD; Finch MB; Martin B
    Ann Rheum Dis; 1998 Apr; 57(4):258. PubMed ID: 9709189
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bronchodilator capacity of salbutamol aerosol after its long-term use].
    Szmidt M; Kosiński SW; Rózniecki J
    Pol Arch Med Wewn; 1983; 70(5-6):251-8. PubMed ID: 6677889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 6. [Salbutamol in children with CARA; a comparison of administration with tablets and with the Rotahaler].
    van der Ploeg RJ; Tolhoek HJ; Akkerboom JC; Knol K
    Tijdschr Kindergeneeskd; 1981 Jun; 49(3):92-9. PubMed ID: 7302939
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
    Emerman CL; Cydulka RK
    Ann Emerg Med; 1997 Apr; 29(4):474-8. PubMed ID: 9095007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease.
    Adelman HM; Winters PR; Mahan CS; Wallach PM
    Am J Med Sci; 1995 Apr; 309(4):191-3. PubMed ID: 7900739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
    Sorbini CA; Todisco T; Boschetti E
    Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
    [No Abstract]   [Full Text] [Related]  

  • 10. Experiences with large doses of beta 2-agonists inhaled from nebulizers.
    Larsson S
    Postgrad Med J; 1983; 59 Suppl 3():71-2. PubMed ID: 6647211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease.
    Shim CS; Williams MH
    Am J Med; 1983 Oct; 75(4):697-701. PubMed ID: 6624778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group.
    Gross N; Tashkin D; Miller R; Oren J; Coleman W; Linberg S
    Respiration; 1998; 65(5):354-62. PubMed ID: 9782217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled powder and aerosol salbutamol in metacholine-induced bronchial obstruction.
    Lahdensuo A; Sovijärvi A; Muittari A
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():515-7. PubMed ID: 6352312
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
    Würtemberger G; Weil R; Schulte-Mönting J; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():304-6. PubMed ID: 2902608
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of salbutamol in patients with chronic obstructive lung disease (author's transl)].
    Pasquis P; Nouvet G; Denis P; David P; Lefrançois R; Morère P
    Therapie; 1981; 36(1):81-5. PubMed ID: 7233376
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of terbutaline Turbuhaler and albuterol chlorofluorocarbon (CFC) inhaler in middle-aged and elderly patients with obstructive lung disease.
    Aalto E; Havu M; Kotaniemi J; Nieminen P; Svahn T; Svensson M; Valta R
    Ann Allergy; 1992 Jul; 69(1):33-6. PubMed ID: 1626757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with aerosol therapy in chronic obstructive lung disease.
    Chryssidis E; Frewin DB; Frith PA; Dawes ER
    N Z Med J; 1981 Nov; 94(696):375-7. PubMed ID: 6948205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory failure due to a massive rheumatoid pleural effusion.
    Pritikin JD; Jensen WA; Yenokida GG; Kirsch CM; Fainstat M
    J Rheumatol; 1990 May; 17(5):673-5. PubMed ID: 2359079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Do the severity and duration of rheumatoid arthritis influence pulmonary ventilation?].
    Börngen U
    Z Rheumatol; 1975; 34(7-8):223-33. PubMed ID: 1101571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressurized aerosol inhaler technique: how important are inhalation from residual volume, inspiratory flow rate and the time interval between puffs?
    Lawford P; McKenzie D
    Br J Dis Chest; 1983 Jul; 77(3):276-81. PubMed ID: 6615704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.